Cucurbitacin B targets PPAT to suppress de novo purine biosynthesis in esophageal squamous cell carcinoma
{{output}}
Background: The de novo purine biosynthesis (DNPB) pathway is increasingly recognized as a key driver of tumor progression. Nevertheless, its precise role in regulating esophageal squamous cell carcinoma (ESCC) growth, radiosensi... ...
